- Research works
- 2 ▲ 216% vs 2013–17
- Citations
- 11 7.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 21% world 28%
Not ranked overall: Harmonex (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Harmonex (United States) publish most on?
By volume: Attention Deficit Hyperactivity Disorder, Mental Health Research Topics, Child and Adolescent Psychosocial and Emotional Development and Pharmacology and Obesity Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
- 2 Mental Health Research Topics Experimental and Cognitive Psychology 0 works
- 3 Child and Adolescent Psychosocial and Emotional Development Clinical Psychology 0 works
- 4 Pharmacology and Obesity Treatment Pharmacology 0 works
- 5 Traumatic Brain Injury Research Epidemiology 0 works
- 6 Sleep and related disorders Experimental and Cognitive Psychology 0 works
- 7 Transcranial Magnetic Stimulation Studies Neurology 0 works
- 8 Maternal Mental Health During Pregnancy and Postpartum Public Health, Environmental and Occupational Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Harmonex (United States)'s research output changed?
Output in 2018–2022 was 216% higher than in 2013–2017.
Other research institutions in Dothan
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.